A new study led by investigators from Mass General Brigham shows that a brain waste- "clean-up" system is influenced by ...
Angiotensin-converting enzyme (ACE) inhibitors were found to be independently associated with reducing all-cause mortality in ...
The Phase 3 ACCEL clinical trial represents important progress in Ardelyx’s goal of expanding the patient population who may benefit from IBSRELA, beyond its lead indication for irritable bowel ...
The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...
Low-sodium oxybate reduces 24-hour sleep duration and daytime napping in adults with idiopathic hypersomnia, according to a phase 3 trial analysis.
This condition has been described by Michael J. Stephen in his 2021 book “Breath Taking” as the “most frustrating and disheartening of all the diseases in pulmonary medicine.” Over a frighteningly ...
Idiopathic hypersomnia treatment should be determined based on factors like symptom profile, age, comorbidities, and additional medications, says review. Treatments to manage idiopathic hypersomnia ...
The patient samples (formalin-fixed biopsies) from the files of Weill Cornell Medical Center or the Medical College of Wisconsin had an IRB-approved protocol that de-identified all data except for the ...
Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment
IDIOPATHIC PULMONARY FIBROSIS (IPF) is a progressive and lethal pulmonary fibrotic lung disease. The diagnostic histological changes are called usual interstitial pneumonia and are characterized by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results